This 2019 randomized, double-blind, placebo-controlled trial, published in Diabetes, Obesity and Metabolism, assessed the impact of selenium supplementation on glycemic control, specifically HbA1c levels, in a cohort of 491 adults aged 60–74 years without diabetes at baseline. Participants were randomized to receive 100 µg/day, 200 µg/day of selenium, or a
